JAK2 and acquired polycythemia vera: Two male patients received higher doses (one patient with JAK2 positive polycythemia rubra vera (PRV) receiving 1 ml/kg) the other was young, unusually had no other comorbidities, had a very good exercise tolerance and was deemed “relatively fit” compared to the other subjects.